dural graft matrix

dural graft matrix

Neurosurgery A biosynthetic substrate indicated for repair of the dura mater in the cranial cavity and spinal cord
References in periodicals archive ?
The DuraGen(tm) Dural Graft Matrix, which received FDA 510(k) clearance and CE Mark certification in 1999, is an innovative collagen matrix for repair of the dura mater, the casing that surrounds the brain, after it has been damaged by surgery or trauma.
Essig, Integra's president and chief executive officer, commented, "ArthroCare's neurosurgery product set is the perfect complement to our Selector(R) Integra Ultrasonic Aspirator and our DuraGen(TM) Dural Graft Matrix, which are regularly used around the world in neuro tumor surgery.
The newly patented dural graft, marketed as the DuraGen dural graft matrix, allows a new method of dural closure that does not require suturing to achieve a watertight dural closure.
DuraGen(R) Dural Graft Matrix for the sutureless repair of the dura mater; -- INTEGRA(R) Dermal Regeneration Template for regeneration of the dermis; and -- BioMend(R) and BioMend(R) Extend Absorbable Collagen Membrane for guided tissue repair of the gingiva.
The first device, the DuraGen(TM) Dural Graft Matrix for the repair of the dura mater membrane that covers the brain and spinal cord, received FDA 510(k) clearance and CE Mark Certification in 1999 and was launched in the third quarter of 1999.
Integra's leading tissue regeneration products include DuraGen(TM) Dural Graft Matrix (for repair and regeneration of dura mater), INTEGRA(R) Dermal Regeneration Template (for regeneration of dermis, sold through the Ethicon division of Johnson & Johnson) and the Biomend(R) Absorbable Collagen Membrane (for the guided repair of the gingiva).
4 million of new equity capital to come from investment affiliates of Soros Private Equity Partners LLC and the continued organic sales growth of our core products, including particularly sales of the DuraGen(TM) dural graft matrix, we are pleased that we are continuing to make progress into the new year.
In particular, sales of the DuraGen(TM) Dural Graft Matrix through Integra NeuroSciences continue to be very satisfying.
The newly patented dural graft, marketed as the DuraGen(TM) dural graft matrix, allows a new method of dural closure that does not require suturing to achieve a watertight dural closure.
Integra's newest neurosurgical medical device, DuraGen(TM) Dural Graft Matrix, recently received the CE Mark Certification for marketing in the European Union, and is currently under FDA review.
Essig, Integra president and chief executive officer, commented, "ArthroCare's neurosurgery product set is the perfect complement to our Selector(R) Integra Ultrasonic Aspirator and our DuraGen(TM) Dural Graft Matrix, which are regularly used around the world in neuro tumor surgery.
The Company believes the worldwide dural graft matrix market is approximately $40 million, of which the European market is estimated at 25 percent.